Lupus nephritis: current issues
- PMID: 12922947
- PMCID: PMC1754664
- DOI: 10.1136/ard.62.9.795
Lupus nephritis: current issues
Abstract
Despite the development of new modalities, cyclophosphamide (CYC) remains the preferred initial treatment for severe proliferative lupus nephritis. Controversies continue about the best route, dosage, and duration of CYC treatment. For recalcitrant disease, new immunosuppressive and immunomodulating agents, immunoablative high dose CYC, nucleoside analogues, apheresis, and the biological response modifiers can be considered.
Similar articles
-
Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.Nephrol Dial Transplant. 2016 Oct;31(10):1561-6. doi: 10.1093/ndt/gfw289. Epub 2016 Sep 1. Nephrol Dial Transplant. 2016. PMID: 27591327
-
[Immunosuppresive treatment in patients with lupus glomerulonephritis. Review of adverse events].Reumatol Clin. 2006 Nov;2(6):313-21. doi: 10.1016/S1699-258X(06)73067-4. Epub 2008 Dec 10. Reumatol Clin. 2006. PMID: 21794349 Spanish.
-
Therapeutic options for resistant lupus nephritis.Semin Arthritis Rheum. 2006 Oct;36(2):71-81. doi: 10.1016/j.semarthrit.2006.04.008. Epub 2006 Jul 12. Semin Arthritis Rheum. 2006. PMID: 16884971 Review.
-
Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.Chin Med J (Engl). 2002 May;115(5):705-9. Chin Med J (Engl). 2002. PMID: 12133539 Clinical Trial.
-
Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis?Kidney Int. 2012 Dec;82(12):1256-60. doi: 10.1038/ki.2012.203. Epub 2012 May 30. Kidney Int. 2012. PMID: 22648298 Review.
Cited by
-
Novel therapeutic agents in clinical development for systemic lupus erythematosus.BMC Med. 2013 May 3;11:120. doi: 10.1186/1741-7015-11-120. BMC Med. 2013. PMID: 23642011 Free PMC article. Review.
-
Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.Rheumatol Int. 2009 Jul;29(9):1057-67. doi: 10.1007/s00296-009-0905-8. Epub 2009 Apr 21. Rheumatol Int. 2009. PMID: 19381639
-
[Glucocorticoid therapy in collagen diseases diseases].Z Rheumatol. 2005 Apr;64(3):162-9. doi: 10.1007/s00393-005-0721-9. Z Rheumatol. 2005. PMID: 15868333 Review. German.
-
Clinical and laboratory predictors of distinct histopathogical features of lupus nephritis.Medicine (Baltimore). 2015 May;94(21):e829. doi: 10.1097/MD.0000000000000829. Medicine (Baltimore). 2015. PMID: 26020385 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources